Istvan Toth

Biography

Professor Toth was a Postdoctoral Fellow at Carleton University, Ottawa Canada (1974-76, Prof J.W. ApSimon). He returned to Hungary to work as a Research Associate (1977-82), then Scientific Group Leader (1982-1987) at the Central Research Institute for Chemistry, Hungarian Academy of Science. Professor Toth joined the School of Pharmacy at the University of London in 1987 as a Senior Lecturer and Royal Society sponsored Senior Research Fellow. He became a Reader in Medicinal Organic Chemistry in 1994 before relocating to The University of Queensland in 1998. Professor Toth has since been appointed as a Fellow of both the Royal Australian Chemical Institute (2008) and the Queensland Academy of Arts and Sciences (2009). He has more than 300 publications and 43 patents.

Research Interest

Professor Toth’s major research interests are drug delivery, immunoadjuvants, carbohydrates, lipids, peptides, nucleosides and nucleotides. New developments in drug/vaccine delivery will clearly have a strong economic impact on the pharmaceutical and biotechnology industries. At the School of Pharmacy, University of London, and at The University of Queensland, Professor Toth has built up a strong, very productive research group (presently about 25 members), where the research orientation is well suited to the direction of modern multidisciplinary pharmaceutical sciences. Professor Toth also has a keen interest in research commercialisation. He is one of the founding members of Alchemia (listed on the Australian Stock Exchange), Implicit Biosciences Pty Ltd and Neurotide. Professor Toth is also a key partner in the Queensland Preclinical Drug Development Facility (TetraQ), established in 2005 as a world-class facility to provide integrated preclinical drug development services to Queensland and Australian biotechnology companies engaged in human therapeutics development. Professor Toth’s primary research goal is to develop versatile delivery mechanisms that can be adapted to suit a broad range of drug and vaccine candidates. Secondary Research Areas: Infection and Immunity Nanotechnology and Materials Chemistry